People

Prominent world leader in the fields of national R&D policies and planning, innovation, technology-based investments.

• Chief scientist and director general ofthe Israel Ministry of Industry and Trade
• Senior consultant to the World Bank on national R&D policies
• Consultant to many countries, including: Singapore, Korea, South Africa, Serbia, Poland
• Chair of the U.S.-Israel Industrial R&D Foundation
• Joint chair of the U.S.-Israel Science and Technology Commission
• Vice president and general manager of Elop Electro-Optic Industries Ltd.’s (Elop) marine and aerial operations and head of the Laser Branch of the Israel Ministry of Defense.

Dr. Gleitman serves as the honorary consul general of Singapore to Israel and is an Honorary citizen of Guangzhou.

Dr. Gleitman holds bachelors of science, master of science and PhD degrees in physical chemistry from the Hebrew University of Jerusalem

World expert in healthcare R&D, healthcare management, and clinical trials. Head of Israel’s largest medical center in charge of all R&D activities, licensing and technology transfer

• Sheba Medical Center
  • Vice President and Acting Director for Research and Development
  • Founder and Chair of Sheba Tech Transfer Company over 20 years
  • Director of the Chaim Sheba Medical Center Rehabilitation Hospital
  • Responsible for clinical trials (2000 annually)
  • Chairman of the Helsinki Committee (Institutional Review Board)
  • Chairman of the Patents Committee
• Professor of Medicine at the Sackler School of Medicine, Tel Aviv University

As a board certified in Psychiatry and Health Care Management, Prof. Noy has decades of experience in clinical, medical research in epidemiology, promoting research at the Chaim Sheba Medical Center, health care management, medical education and management processes and change in medicine and medical research/ R&D, on both the international and national levels and has published more than 80 articles, book chapters.

Prof. Noy received his Ph.D. in Health Policy from Tel Aviv University; M.D. The Hebrew University Hadassah Medical School and he received his M.B.A. INSEAD, Fontainebleau, France.

Professional VC investor in life sciences companies with vast experience and proven track

• 2004 to 2015 Partner and Managing Director of Israel Healthcare Ventures (IHCV), a prominent Israeli life sciences venture capital fund
• Co-Founder & CEO of Life Sciences Transaction Support Ltd. (LTS), a PwC subsidiary dealing with life sciences investment banking
• Served as independent board member in 7 industrial public companies (including Raval ICS Ltd. and Ram-On Investments and Holdings (1999) Ltd)
• Represented IHCV and represents GIBF in numerous portfolio companies
• Prior to turning to the private sector, Avner served in senior positions at the Israeli Prime Minister Chamber and the Israeli Supreme Court

Significant experience in government relationship and strong knowledge of international high-tech transfer and governmental development plans in China

• Co-leader of Shanghai International Cleantech Accelerator, 
• Chief Researcher of South North Institute of Sustainable Development (SNISD)
• Senior Adviser of China Carbon Forum(CCF)
• 1983 to 1991 worked for International Department of Ministry of Foreign Affairs of PRC, including 4 years for Chinese mission to UN in New York. Chinese representative to various international economic organizations such as IMF, World Bank and WTO. He had initiated and pushed forward Chinese participation in PECC (Pacific Economic Cooperation Council) and Asian Development Bank
• Consulting service to Chinese government and enterprises in the field of international relationship.

Assistant Secretary General and Deputy Secretary General for the International Scientific Exchange Foundation of China (ISEFC). In this NGO he initiated some innovative international projects for high tech cooperation and commercialization mainly in new energy, cleantech, biotech and new agriculture

• Join GIBF Group in 2018 after serving as Deputy Director at the Economic and Innovation Department of the Israeli Embassy in Beijing.

• Mandarin-speaking business executive and consultant for technology-oriented companies, with expertise in medical device and biotech ventures in Greater China.

• Skilled in formulating go-to-market strategy, investor relations, business plan preparation, sales and distribution channel management, and leading new business and product development teams.

• Dr. Li is in charge of due diligence and contacts Chinese KOLs regulatory expertise.
• Dr. Li holds a Ph.D. in Molecular Biology from Hong Kong Baptist University.